Answers are grounded in this paper and cite their sources.
The NSCLC is a severe and common chronic disease in the whole world, and it has high mortality, which threatens human life. Therefore, the treatment of NSCLC is a hot topic in both society and the medical field. Nowadays, the treatment of NSCLC has many choices, for example, chemotherapeutic agents and radiotherapy drug treatments, these treatments of NSCLC are limited and have a lot of side effects to the patients, like unavoidable vomiting, hair loss, etc. The immunotherapist is the latest cancer treatment and it can improve curative effects and reduce adverse reactions. This article is based on the mechanism of NSCLC incidence and development and discusses the immunotherapies of NSCLC including the monoclonal antibody, immunity checkpoint inhibitors, and tumor therapeutic vaccines. It talks about the mechanisms of these treatments and the recent research findings of these treatments. It can provide references to the NSCLC clinical treatment and the clinical application of immunotherapies fields. This article also mentions the limitations and the challenges of tumor therapeutic vaccines, which can inspire researchers to find solutions and the progress of relevant limitations and challenges.
No takes yet. Share an insight, caveat, or question.
Jun Gu (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: